On October 16, 2025, Entero Therapeutics, Inc. (NASDAQ: ENTO) announced the launch of Grid AI Corp., a new subsidiary focused on AI‑driven energy infrastructure. The company described Grid AI Corp. as a platform that will redefine how artificial intelligence infrastructure connects to the power grid, addressing the growing bottleneck in power supply for AI workloads.
Entero Therapeutics, traditionally a biotechnology company, is expanding into the AI energy sector, signaling a strategic pivot toward high‑growth infrastructure markets. The launch follows the company’s earlier announcement in October 2025 of a pivot to AI energy infrastructure, but the new entity represents a distinct operational arm dedicated to this technology.
The move is intended to diversify Entero’s revenue streams and leverage its expertise in targeted, non‑systemic therapies to develop AI solutions that optimize grid performance. By establishing Grid AI Corp., the company aims to capture a share of the rapidly expanding AI infrastructure market, potentially creating new growth opportunities beyond its core biopharmaceutical pipeline.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.